Synektik SA
Synektik maintains a strong liquidity position with a current ratio of 1.65 and cash and equivalents of 84.25 million PLN, which supports operational flexibility and short-term obligations. The company's debt-to-equity ratio of 0.18 indicates a conservative capital structure, with long-term debt at 40.23 million PLN and total equity at 222.78 million PLN. Free cash flow of 57.36 million PLN and operating cash flow of 77.73 million PLN further reinforce its liquidity profile. The company's profitability is robust, with a return on equity of 45.87% and return on assets of 21%, both exceeding typical thresholds for the healthcare equipment industry. Operating income of 157.02 million PLN and net income of 102.19 million PLN reflect strong cost control and revenue generation. Gross profit of 242.59 million PLN on revenue of 681.29 million PLN suggests a healthy margin structure. Synektik's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the latest financials. This lack of diversification may expose the company to regional market risks, particularly in the healthcare equipment sector. The company's growth trajectory is supported by strong analyst sentiment, with a mean price target of 319.38 PLN and a median of 312.65 PLN. Analysts have issued three strong-buy and two buy recommendations, with no hold or negative ratings. The absence of negative analyst sentiment suggests confidence in the company's near-term performance. Risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The company's capital structure remains stable, with no dilution potential identified in the latest financial data. However, the healthcare equipment industry is subject to regulatory and technological changes, which could impact long-term performance. Recent events include strong analyst coverage and positive price target estimates, with no disclosed earnings call transcripts or regulatory filings indicating material changes in the company's operations. The absence of recent negative events supports the current positive outlook.
Business. Synektik SA develops and distributes advanced medical equipment and technology solutions, primarily serving healthcare institutions and providers.
Classification. Synektik is classified in the Healthcare sector under Advanced Medical Equipment & Technology with a confidence level of 0.92.
- Synektik maintains a strong liquidity position with a current ratio of 1.65 and 84.25 million PLN in cash and equivalents.
- The company's profitability is robust, with a return on equity of 45.87% and return on assets of 21%.
- Analysts have issued three strong-buy and two buy recommendations, with no hold or negative ratings.
- The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification.
- Risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected.
- --
- ## RATIONALES
- ```json
- No immediate filing-based liquidity or dilution flags were detected.